BioHarvest Sciences (NASDAQ:BHST) vs. Honest (NASDAQ:HNST) Financial Comparison

Honest (NASDAQ:HNST) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk.

Profitability

This table compares Honest and BioHarvest Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Honest	-3.56%	4.31%	3.33%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

Volatility and Risk

Honest has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.

Institutional and Insider Ownership

45.5% of Honest shares are owned by institutional investors. 9.4% of Honest shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Honest and BioHarvest Sciences”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Honest	$371.32 million	1.54	-$15.69 million	($0.11)	-47.27
BioHarvest Sciences	$35.48 million	1.13	-$11.14 million	($0.52)	-3.94

BioHarvest Sciences has lower revenue, but higher earnings than Honest. Honest is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for Honest and BioHarvest Sciences, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Honest	2	4	2	1	2.22
BioHarvest Sciences	1	0	2	0	2.33

Honest currently has a consensus target price of $4.84, suggesting a potential downside of 6.92%. BioHarvest Sciences has a consensus target price of $6.50, suggesting a potential upside of 217.07%. Given BioHarvest Sciences’ stronger consensus rating and higher possible upside, analysts plainly believe BioHarvest Sciences is more favorable than Honest.

Summary

Honest beats BioHarvest Sciences on 10 of the 14 factors compared between the two stocks.

About Honest

The Honest Company, Inc. manufactures and sells diapers and wipes, skin and personal care, and household and wellness products. The company also offers baby clothing and nursery bedding products. It sells its products through digital and retail sales channels, such as its website and third-party ecommerce sites, as well as brick and mortar retailers. The company was incorporated in 2012 and is headquartered in Los Angeles, California.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.